Tapewire

Nasdaq · USD

URGN

UroGen Pharma Ltd.

Export transactions ↓
Tapewire entity
4466
SEC CIK
0001668243
Parsed reports
233

Last 12 months

Inside the activity.

0 purchase rows · 15 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202606
Mar 202600
Apr 202600
May 202601
Jun 202602
Jul 202601
Aug 202601
Sep 202602
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 08, 2026 Filed Oct 9, 2026 16:57 UTC
Degnan ChrisChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 4,483 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-032421 · rdgdoc.xml · derivative · entry 3

Degnan Chris · CIK 0001741968 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,484

Underlying: Ordinary Shares · 4,483 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

F3 · derivative.exercise_date: The reporting person was granted RSUs on October 8, 2024 representing 13,450 ordinary shares. The RSUs will vest in three equal annual installments from October 8, 2025.

F3 · derivative.expiration_date: The reporting person was granted RSUs on October 8, 2024 representing 13,450 ordinary shares. The RSUs will vest in three equal annual installments from October 8, 2025.

Read SEC document
October 08, 2026 Filed Oct 9, 2026 16:57 UTC
Degnan ChrisChief Financial Officer
SaleOrdinary Shares 2,202 $36.69 $80,791.38
Disclosure

SEC source: 0001437749-26-032421 · rdgdoc.xml · nonDerivative · entry 2

Degnan Chris · CIK 0001741968 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,561

F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.

Read SEC document
October 08, 2026 Filed Oct 9, 2026 16:57 UTC
Degnan ChrisChief Financial Officer
Exercise / conversionOrdinary Shares 4,483 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-26-032421 · rdgdoc.xml · nonDerivative · entry 1

Degnan Chris · CIK 0001741968 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,763

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

Read SEC document
September 08, 2026 Filed Sep 9, 2026 18:37 UTC
Schoenberg MarkChief Medical Officer
SaleOrdinary Shares 871 $42.92 $37,383.32
Disclosure

SEC source: 0001437749-26-029965 · rdgdoc.xml · nonDerivative · entry 2

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,882

F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.

Read SEC document
September 08, 2026 Filed Sep 9, 2026 18:35 UTC
Smith Jason DrewGeneral Counsel
SaleOrdinary Shares 1,519 $42.54 $64,618.26
Disclosure

SEC source: 0001437749-26-029963 · rdgdoc.xml · nonDerivative · entry 2

Smith Jason Drew · CIK 0001821479 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,141

F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.

Read SEC document
September 07, 2026 Filed Sep 9, 2026 18:37 UTC
Schoenberg MarkChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 1,667 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-029965 · rdgdoc.xml · derivative · entry 3

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 1,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

F3 · derivative.exercise_date: The reporting person was granted RSUs on September 7, 2023 representing 5,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024.

F3 · derivative.expiration_date: The reporting person was granted RSUs on September 7, 2023 representing 5,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024.

Read SEC document
September 07, 2026 Filed Sep 9, 2026 18:37 UTC
Schoenberg MarkChief Medical Officer
Exercise / conversionOrdinary Shares 1,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-26-029965 · rdgdoc.xml · nonDerivative · entry 1

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,753

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

Read SEC document
September 07, 2026 Filed Sep 9, 2026 18:35 UTC
Smith Jason DrewGeneral Counsel
Exercise / conversionRestricted Stock Units · Derivative 3,334 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-029963 · rdgdoc.xml · derivative · entry 3

Smith Jason Drew · CIK 0001821479 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 3,334 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

F3 · derivative.exercise_date: The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024.

F3 · derivative.expiration_date: The reporting person was granted RSUs on September 7, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024.

Read SEC document
September 07, 2026 Filed Sep 9, 2026 18:35 UTC
Smith Jason DrewGeneral Counsel
Exercise / conversionOrdinary Shares 3,334 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-26-029963 · rdgdoc.xml · nonDerivative · entry 1

Smith Jason Drew · CIK 0001821479 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

Read SEC document
August 26, 2026 Filed Aug 28, 2026 16:01 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-029175 · rdgdoc.xml · derivative · entry 2

Robinson James A. Jr. · CIK 0001734295 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer

F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer

Read SEC document
August 26, 2026 Filed Aug 28, 2026 16:01 UTC Exercise / conversionordinary shares 2,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-26-029175 · rdgdoc.xml · nonDerivative · entry 1

Robinson James A. Jr. · CIK 0001734295 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer

Read SEC document
August 20, 2026 Filed Aug 24, 2026 21:03 UTC
Schoenberg MarkChief Medical Officer
Saleordinary shares 60,677 $47.05 $2,854,852.85
Disclosure

SEC source: 0001437749-26-028840 · rdgdoc.xml · nonDerivative · entry 1

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,086

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.30 to $49.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 09, 2026 Filed Jul 10, 2026 18:17 UTC
Schoenberg MarkChief Medical Officer
SaleOrdinary Shares 10,000 $40.00 $400,000.00
Disclosure

SEC source: 0001437749-26-023290 · rdgdoc.xml · nonDerivative · entry 1

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,763

F1 · kind: Transaction made pursuant to a duly adopted trading plan under Rule 10b5-1(c). The adoption date of the referenced Rule 10b5-1(c) plan is August 15, 2025. This transaction represents the final sale under such trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 and $40.02. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 14:22 UTC
Schoenberg MarkChief Medical Officer
SaleOrdinary Shares 10,000 $35.01 $350,100.00
Disclosure

SEC source: 0001437749-26-021523 · rdgdoc.xml · nonDerivative · entry 1

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 129,763

F1 · kind: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). Adoption date of referenced 10b5-1(c) plan is: 08-15-2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 and $35.08. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 10:01 UTC GrantStock Option (right ot buy) · Derivative 20,000 $0.00 Strike: $34.99 $0.00
Disclosure

SEC source: 0001437749-26-021515 · rdgdoc.xml · derivative · entry 1

Holden Stuart · CIK 0001763999 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Ordinary Shares · 20,000 shares

Expires 2036-06-22

F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 14:03 UTC GrantRestricted Stock Unit · Derivative 8,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-021519 · rdgdoc.xml · derivative · entry 2

Wildman Daniel George · CIK 0001952679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Ordinary Shares · 8,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

F3 · derivative.exercise_date: The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

F3 · derivative.expiration_date: The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 14:03 UTC GrantStock Option (right ot buy) · Derivative 10,000 $0.00 Strike: $34.99 $0.00
Disclosure

SEC source: 0001437749-26-021519 · rdgdoc.xml · derivative · entry 1

Wildman Daniel George · CIK 0001952679 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Ordinary Shares · 10,000 shares

Expires 2036-06-22

F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 14:02 UTC GrantRestricted Stock Unit · Derivative 8,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-021517 · rdgdoc.xml · derivative · entry 2

Robinson James A. Jr. · CIK 0001734295 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Ordinary Shares · 8,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

F3 · derivative.exercise_date: The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

F3 · derivative.expiration_date: The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 14:02 UTC GrantStock Option (right ot buy) · Derivative 10,000 $0.00 Strike: $34.99 $0.00
Disclosure

SEC source: 0001437749-26-021517 · rdgdoc.xml · derivative · entry 1

Robinson James A. Jr. · CIK 0001734295 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Ordinary Shares · 10,000 shares

Expires 2036-06-22

F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 14:00 UTC GrantRestricted Stock Unit · Derivative 8,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-021513 · rdgdoc.xml · derivative · entry 2

BUTITTA CYNTHIA M · CIK 0001222082 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Ordinary Shares · 8,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer

F3 · derivative.exercise_date: The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

F3 · derivative.expiration_date: The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 14:00 UTC GrantStock Option (right ot buy) · Derivative 10,000 $0.00 Strike: $34.99 $0.00
Disclosure

SEC source: 0001437749-26-021513 · rdgdoc.xml · derivative · entry 1

BUTITTA CYNTHIA M · CIK 0001222082 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Ordinary Shares · 10,000 shares

Expires 2036-06-22

F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 13:58 UTC
WEN LEANADirector
GrantRestricted Stock Unit · Derivative 8,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-021511 · rdgdoc.xml · derivative · entry 2

WEN LEANA · CIK 0001847598 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Ordinary Shares · 8,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

F3 · derivative.exercise_date: The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

F3 · derivative.expiration_date: The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 13:58 UTC
WEN LEANADirector
GrantStock Option (right ot buy) · Derivative 10,000 $0.00 Strike: $34.99 $0.00
Disclosure

SEC source: 0001437749-26-021511 · rdgdoc.xml · derivative · entry 1

WEN LEANA · CIK 0001847598 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Ordinary Shares · 10,000 shares

Expires 2036-06-22

F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

Read SEC document
June 22, 2026 Filed Jun 24, 2026 13:57 UTC GrantStock Option (right ot buy) · Derivative 20,000 $0.00 Strike: $34.99 $0.00
Disclosure

SEC source: 0001437749-26-021509 · rdgdoc.xml · derivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Ordinary Shares · 20,000 shares

Expires 2036-06-22

F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

Read SEC document
June 08, 2026 Filed Jun 9, 2026 17:59 UTC
Schoenberg MarkChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 10,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-019964 · rdgdoc.xml · derivative · entry 3

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

F3 · derivative.exercise_date: The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2024.

F3 · derivative.expiration_date: The reporting person was granted RSUs on June 8, 2023 representing 30,000 ordinary shares. The RSUs will vest in three equal annual installments from June 8, 2024.

Read SEC document
June 08, 2026 Filed Jun 9, 2026 17:59 UTC
Schoenberg MarkChief Medical Officer
SaleOrdinary Shares 5,222 $27.30 $142,560.60
Disclosure

SEC source: 0001437749-26-019964 · rdgdoc.xml · nonDerivative · entry 2

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,763

F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.

Read SEC document
June 08, 2026 Filed Jun 9, 2026 17:59 UTC
Schoenberg MarkChief Medical Officer
Exercise / conversionOrdinary Shares 10,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-26-019964 · rdgdoc.xml · nonDerivative · entry 1

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,985

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

Read SEC document
May 26, 2026 Filed May 27, 2026 12:04 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-018442 · rdgdoc.xml · derivative · entry 2

Robinson James A. Jr. · CIK 0001734295 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Ordinary Shares · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer

F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer

Read SEC document
May 26, 2026 Filed May 27, 2026 12:04 UTC Exercise / conversionordinary shares 2,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-26-018442 · rdgdoc.xml · nonDerivative · entry 1

Robinson James A. Jr. · CIK 0001734295 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer

Read SEC document
May 08, 2026 Filed May 11, 2026 19:54 UTC
Schoenberg MarkChief Medical Officer
SaleOrdinary Shares 10,000 $30.00 $300,000.00
Disclosure

SEC source: 0001437749-26-016104 · rdgdoc.xml · nonDerivative · entry 1

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 134,985

F1 · kind: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). Adoption date of referenced 10b5-1(c) plan is: 08-15-2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 and $30.05. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
February 03, 2026 Filed Feb 5, 2026 00:37 UTC
Schoenberg MarkChief Medical Officer
SaleOrdinary Shares 3,686 $19.69 $72,577.34
Disclosure

SEC source: 0001437749-26-003040 · rdgdoc.xml · nonDerivative · entry 3

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,985

F1 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.

Read SEC document
February 03, 2026 Filed Feb 5, 2026 00:37 UTC
Schoenberg MarkChief Medical Officer
SaleOrdinary Shares 1,843 $19.69 $36,288.67
Disclosure

SEC source: 0001437749-26-003040 · rdgdoc.xml · nonDerivative · entry 2

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,671

F1 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.

Read SEC document
February 03, 2026 Filed Feb 5, 2026 00:37 UTC
Schoenberg MarkChief Medical Officer
SaleOrdinary Shares 1,844 $19.69 $36,308.36
Disclosure

SEC source: 0001437749-26-003040 · rdgdoc.xml · nonDerivative · entry 1

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,514

F1 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.

Read SEC document
February 03, 2026 Filed Feb 11, 2026 19:54 UTC
Smith Jason DrewGeneral Counsel
SaleOrdinary Shares 3,217 $19.69 $63,342.73
Disclosure

SEC source: 0001437749-26-003778 · rdgdoc.xml · nonDerivative · entry 6

Smith Jason Drew · CIK 0001821479 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,588

F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.

Read SEC document
February 03, 2026 Filed Feb 11, 2026 19:54 UTC
Smith Jason DrewGeneral Counsel
SaleOrdinary Shares 1,608 $19.69 $31,661.52
Disclosure

SEC source: 0001437749-26-003778 · rdgdoc.xml · nonDerivative · entry 4

Smith Jason Drew · CIK 0001821479 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,326

F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.

Read SEC document
February 03, 2026 Filed Feb 11, 2026 19:54 UTC
Smith Jason DrewGeneral Counsel
SaleOrdinary Shares 2,654 $19.69 $52,257.26
Disclosure

SEC source: 0001437749-26-003778 · rdgdoc.xml · nonDerivative · entry 2

Smith Jason Drew · CIK 0001821479 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,934

F2 · shares: Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 22:18 UTC
Schoenberg MarkChief Medical Officer
GrantRestricted Stock Units · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-002843 · rdgdoc.xml · derivative · entry 7

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Ordinary Shares · 20,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

F5 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029.

F5 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 22:18 UTC
Schoenberg MarkChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 3,334 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-002843 · rdgdoc.xml · derivative · entry 6

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 3,334 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

F3 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024.

F3 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 22:18 UTC
Schoenberg MarkChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 6,666 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-002843 · rdgdoc.xml · derivative · entry 5

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,334

Underlying: Ordinary Shares · 6,666 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

F2 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2025 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026.

F2 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2025 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 22:18 UTC
Schoenberg MarkChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 3,333 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-002843 · rdgdoc.xml · derivative · entry 4

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,334

Underlying: Ordinary Shares · 3,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

F4 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2024 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025.

F4 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2024 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 22:18 UTC
Schoenberg MarkChief Medical Officer
Exercise / conversionOrdinary Shares 3,334 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-26-002843 · rdgdoc.xml · nonDerivative · entry 3

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,359

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 22:18 UTC
Schoenberg MarkChief Medical Officer
Exercise / conversionOrdinary Shares 6,666 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-26-002843 · rdgdoc.xml · nonDerivative · entry 2

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,358

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 22:18 UTC
Schoenberg MarkChief Medical Officer
Exercise / conversionOrdinary Shares 3,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-26-002843 · rdgdoc.xml · nonDerivative · entry 1

Schoenberg Mark · CIK 0001763581 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,692

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

Read SEC document
January 31, 2026 Filed Feb 3, 2026 22:16 UTC
Degnan ChrisChief Financial Officer
GrantRestricted Stock Units · Derivative 32,609 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-002841 · rdgdoc.xml · derivative · entry 1

Degnan Chris · CIK 0001741968 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,609

Underlying: Ordinary Shares · 32,609 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

F2 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029.

F2 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029.

Read SEC document
January 31, 2026 Filed Feb 11, 2026 19:54 UTC
Smith Jason DrewGeneral Counsel
GrantRestricted Stock Units · Derivative 32,609 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-003778 · rdgdoc.xml · derivative · entry 10

Smith Jason Drew · CIK 0001821479 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,609

Underlying: Ordinary Shares · 32,609 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

F6 · derivative.exercise_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029.

F6 · derivative.expiration_date: 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029.

Read SEC document
January 31, 2026 Filed Feb 11, 2026 19:54 UTC
Smith Jason DrewGeneral Counsel
Exercise / conversionRestricted Stock Units · Derivative 6,667 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-003778 · rdgdoc.xml · derivative · entry 9

Smith Jason Drew · CIK 0001821479 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 6,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

F4 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024.

F4 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024.

Read SEC document
January 31, 2026 Filed Feb 11, 2026 19:54 UTC
Smith Jason DrewGeneral Counsel
Exercise / conversionRestricted Stock Units · Derivative 3,333 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-003778 · rdgdoc.xml · derivative · entry 8

Smith Jason Drew · CIK 0001821479 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,667

Underlying: Ordinary Shares · 3,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

F3 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2025 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026.

F3 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2025 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026.

Read SEC document
January 31, 2026 Filed Feb 11, 2026 19:54 UTC
Smith Jason DrewGeneral Counsel
Exercise / conversionRestricted Stock Units · Derivative 5,500 $0.00 $0.00
Disclosure

SEC source: 0001437749-26-003778 · rdgdoc.xml · derivative · entry 7

Smith Jason Drew · CIK 0001821479 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,500

Underlying: Ordinary Shares · 5,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

F5 · derivative.exercise_date: The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025.

F5 · derivative.expiration_date: The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025.

Read SEC document
January 31, 2026 Filed Feb 11, 2026 19:54 UTC
Smith Jason DrewGeneral Counsel
Exercise / conversionOrdinary Shares 6,667 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-26-003778 · rdgdoc.xml · nonDerivative · entry 5

Smith Jason Drew · CIK 0001821479 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,972

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

Read SEC document
January 31, 2026 Filed Feb 11, 2026 19:54 UTC
Smith Jason DrewGeneral Counsel
Exercise / conversionOrdinary Shares 3,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-26-003778 · rdgdoc.xml · nonDerivative · entry 3

Smith Jason Drew · CIK 0001821479 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,805

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.